Biomerica (BMRA) Shareholder's Equity Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Biomerica | 7.12 Mn | 5.78 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -20.73% |
| Nov 30, 2025 | -16.84% |
| Aug 31, 2025 | -16.34% |
| May 31, 2025 | -21.99% |
| Feb 28, 2025 | 3.41% |
| Nov 30, 2024 | 8.66% |
| Aug 31, 2024 | 8.09% |
| May 31, 2024 | 10.61% |
| Feb 29, 2024 | 14.58% |
| Nov 30, 2023 | 16.29% |
| Aug 31, 2023 | 21.43% |
| May 31, 2023 | 22.07% |
| Aug 31, 2022 | 14.19% |
| May 31, 2022 | 13.15% |
| Feb 28, 2022 | 15.15% |
| Nov 30, 2021 | 12.14% |
| Aug 31, 2021 | 11.25% |
| May 31, 2021 | 12.07% |
| Feb 28, 2021 | 14.49% |
| Nov 30, 2020 | 15.29% |
| Aug 31, 2020 | 17.84% |
| May 31, 2020 | 20.47% |
| Feb 29, 2020 | -2.63% |
| Nov 30, 2019 | -9.17% |
| Aug 31, 2019 | -8.66% |
| May 31, 2019 | -7.61% |
| Feb 28, 2019 | -7.14% |
| Nov 30, 2018 | -4.06% |
| Aug 31, 2018 | -6.37% |
| May 31, 2018 | -5.81% |
| Aug 31, 2017 | -4.05% |
| May 31, 2017 | -2.05% |
| Feb 28, 2017 | -0.25% |
| Nov 30, 2016 | 1.53% |
| Aug 31, 2016 | 3.04% |
| May 31, 2016 | 3.81% |